Kritoma

Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (359)Community (0)

GLP-1 receptor agonists for obesity treatment — Research Evidence and Topic... | Kritoma

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

359 papers

SearchSort evidence

All359 Core251 Supporting111 Background0

Showing 121-132 of total 359 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Immunometabolic Regulation of Macrophage Function in Cardio-Hepatic-Renal Comorbidities: Mechanisms and Therapeutic Opportunities.

Bai X; Bai J; Zhou Y

Jan 1, 2026

Molecular and cellular endocrinology

2026PubMedSupporting evidence

Epigenetic determinants of GLP-1 responsiveness: Integrating dietary modulation beyond genetics.

Shin HR; Kim TY; Min K; Park UH; Oh SW; Kim JK

Jan 1, 2026Obesity research & clinical practice

2026PubMedSupporting evidence

GLP-1 agonists before endoscopy: separating fact from fiction.

Shah T

Jan 1, 2026Current opinion in gastroenterology

2026PubMedSupporting evidence

Evidence-Based Management and Functional Outcomes of Femoral Head Avascular Necrosis: A Systematic Review.

Desai S; Shinde S; Desai R; Mane M; Shinde A

Jan 1, 2026Cureus

2026PubMedDirectly related

Targeting the cardiohepatic-metabolic axis: GLP-1-based and incretin multi-agonist therapies in MASH.

Zhang YW; Hu Y

Jan 1, 2026British journal of clinical pharmacology

2026PubMedDirectly related

Association Between Continuous Glucose Monitoring Utilization and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Type 2 Diabetes: A Real-World Study.

Wright EE Jr; Huang E; Bindal A

Jan 1, 2026Diabetes technology & therapeutics

2026PubMedSupporting evidence

Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials.

Shao C; Lin H; Yu J; Chen H; Ren Y; Ren J; Zeng Y; Wu Y; Bai H; Zhang Q; Xiao X

Jan 1, 2026Diabetes, metabolic syndrome and obesity : targets and therapy

2026PubMedDirectly related

Aesthetic Considerations for Preventing and Managing GLP-1 Receptor Agonist-Related Facial Aging.

Bommareddy K; Fabi S; Muniz M

Jan 1, 2026The Journal of clinical and aesthetic dermatology

2026PubMedSupporting evidence

Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study.

Tu CY; Chen HL; Wu YH; Wu MJ

Jan 1, 2026Diabetes research and clinical practice

2026PubMedDirectly related

Cargo-aware design of dissolving microneedles: an FEA-guided rational framework reveals distinct delivery mechanisms for small and large molecules.

Beibei Y; Yang D; Yifeng S; Wenjing T; Wanshan H; Wenhao W; Tingting P; Chuanbin W; Pan X

Jan 1, 2026International journal of pharmaceutics

2026PubMedDirectly related

Liraglutide in Adults With Obesity: A Multicentre, Single-Arm, Post-Marketing Surveillance Study in Taiwan.

Tu ST; Chiu CF; Chou CK; Chuang HH; Hu SW; Ko WC; Lee CY; Lin WY; Sung YJ; Tzeng TF; Wang W; Wu HF; Yeung CY; Chen B; Sim CJ; Huang KC

Jan 1, 2026Endocrinology, diabetes & metabolism

2026PubMedDirectly related

A Novel Approach to Managing "Double Diabetes" in a Pediatric Patient on Insulin Pump Therapy: An Off-Label Use of a Fixed-Ratio Insulin Degludec/Liraglutide Combination.

Almoallem B; Thalange NK

Jan 1, 2026Cureus

Page 11 of 30Showing 121-132 of total 359 results.

1...101112...30